Clincosm LogoSign in Get a demo

Atherosclerosis

Showing 26 - 50 of 809
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atherosclerosis Trial in Beijing (Jetstream System)

Active, not recruiting
  • Atherosclerosis
  • Jetstream System
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Jan 28, 2023

Hypertriglyceridemia, Cardiovascular Diseases, Atherosclerosis Trial in United States (Olezarsen, Placebo)

Recruiting
  • Hypertriglyceridemia
  • +2 more
  • Birmingham, Alabama
  • +17 more
Jan 26, 2023

Cancer, Immune-related Adverse Event, Cardiac Abnormalities, Variable Trial in Belgium (Cardiology consultation, Chest Computed

Recruiting
  • Cancer
  • +6 more
  • Cardiology consultation
  • +4 more
  • Deinze, East-Flanders, Belgium
  • +3 more
Jan 26, 2023

Peripheral Artery Disease, Atherosclerosis, Artery Diseases, Peripheral Trial in Worldwide (device, drug, procedure)

Active, not recruiting
Has Results
  • Peripheral Artery Disease
  • +4 more
  • RANGER™ Paclitaxel Coated Balloon
  • +2 more
  • Fairhope, Alabama
  • +66 more
Jan 24, 2023

A U.S Post Approval Study Evaluating SYNERGY XLV Stent System

Active, not recruiting
  • Atherosclerosis
  • +3 more
  • SYNERGY XLV (Megatron) Coronary Stent System
  • New Haven, Connecticut
  • +7 more
Jan 20, 2023

Coronary Artery Disease, Atherosclerosis Trial in New York, Roslyn (rotational atherectomy, cutting balloon, plain old balloon)

Recruiting
  • Coronary Artery Disease
  • Atherosclerosis
  • rotational atherectomy
  • +2 more
  • New York, New York
  • +1 more
Jan 20, 2023

Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)

Not yet recruiting
  • Hypercholesterolemia
  • +3 more
  • Cambridge, United Kingdom
    University of Cambridge
Jan 13, 2023

Coronary Artery Disease, Atherosclerosis Trial in Seoul (Percutaneous coronary intervention for complex lesion, Drug-eluting

Completed
  • Coronary Artery Disease
  • Atherosclerosis
  • Percutaneous coronary intervention for complex lesion
  • +3 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 16, 2023

Telerobotic Ultrasound for Carotid Imaging - Feasibility Study

Withdrawn
  • Carotid Artery Disease
  • +19 more
  • Ultrasound for Carotid Arteries
  • Telerobotic Ultrasound for Carotid Arteries
  • (no location specified)
Jan 7, 2023

Atherosclerosis Trial in Saint Louis (Standard meal, High animal protein meal, High plant protein meal)

Not yet recruiting
  • Atherosclerosis
  • Standard meal
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 12, 2022

Pre-Eclampsia, Atherosclerosis, Cardiovascular Diseases Trial in Copenhagen, Herlev (Cardiovascular CT)

Active, not recruiting
  • Pre-Eclampsia
  • +3 more
  • Cardiovascular CT
  • Copenhagen, Denmark
  • +2 more
Dec 9, 2022

Innate on the Inflammatory Response to Endotoxin

Recruiting
  • Asthma
  • +4 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Dec 7, 2022

    Atherosclerosis, Ischemia Trial in Beijing (Drug-eluting Stent, Excimer Laser Ablation Combined Drug-coated Balloon)

    Withdrawn
    • Atherosclerosis
    • Ischemia
    • Drug-eluting Stent
    • Excimer Laser Ablation Combined Drug-coated Balloon
    • Beijing, Beijing, China
      Gu Yong Quan
    Dec 4, 2022

    Cardiovascular Diseases, Atherosclerosis, Dyslipidemias Trial (Digitally-enabled Multifaceted Quality Improvement Intervention,

    Not yet recruiting
    • Cardiovascular Diseases
    • +2 more
    • Digitally-enabled Multifaceted Quality Improvement Intervention
    • Usual care
    • (no location specified)
    Nov 14, 2022

    Coronary Artery Calcifications by Whole Blood Transcriptome

    Enrolling by invitation
    • Atherosclerosis
    • +2 more
      • Ciudad Autonoma de Buenos Aires, Argentina
        Clinica Sagrada Familia
      Nov 15, 2022

      Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis Trial in Worldwide (Early Intervention)

      Recruiting
      • Cardiovascular Diseases
      • +3 more
      • Early Intervention
      • Wollongong, New South Wales, Australia
      • +15 more
      Nov 6, 2022

      Blood Endothelium Progenitor Cells and Dendritic Cells as

      Completed
      • Atherosclerosis
      • Restenosis
        • Edegem, Antwerpen, Belgium
          Universitair Ziekenhuis Antwerpen
        Nov 3, 2022

        Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)

        Completed
        • Dyslipidemia
        • +3 more
        • Dallas, Texas
          Covance Clinical Research Unit, Inc.
        Nov 1, 2022

        Hypercholesterolemia, Cardiovascular Risk Factor, Dyslipidemias Trial in Clermont-Ferrand (TOTUM-070)

        Recruiting
        • Hypercholesterolemia
        • +4 more
        • TOTUM-070
        • Clermont-Ferrand, France
          CIC Clermont Ferrand
        Oct 25, 2022

        Studying the Effects of Cannabis on Vasculature

        Not yet recruiting
        • Cardiovascular Diseases
        • +2 more
        • Chronic Cannabis use
        • (no location specified)
        Oct 14, 2022

        ITA Vs LAD; Evaluation of Inflammatory Burden in OP-CABG

        Active, not recruiting
        • Ischemic Heart Disease
        • +3 more
          • Rome, Italy
            European Hospital
          Oct 7, 2022

          Atherosclerosis, Ischemic Stroke Trial in Nottingham (SP-8356, Placebo)

          Terminated
          • Atherosclerosis
          • Ischemic Stroke
          • Nottingham, Mere Way Ruddington Fields Ruddington, United Kingdom
            Quotient Sciences
          Oct 6, 2022

          Cardiovascular Diseases, Atherosclerosis, Inflammation Trial in Ottawa (Colchicine Oral Product, Placebo oral capsule)

          Recruiting
          • Cardiovascular Diseases
          • +3 more
          • Colchicine Oral Product
          • Placebo oral capsule
          • Ottawa, Ontario, Canada
            University of Ottawa Heart Institute
          Oct 3, 2022

          Dyslipidemia, Atherosclerosis, Diabetes, Type 2 Trial (Choline fenofibrate, Policosanol)

          Recruiting
          • Dyslipidemia
          • +2 more
          • Seongnam, Gyeonggi, Korea, Republic of
            SNUBH
          Oct 1, 2022

          Dyslipidemias, Atherosclerosis, Diabetes, Type 2 Trial (Omega 3-Atorvastatin, Atorvastatin-Ezetimibe)

          Recruiting
          • Dyslipidemias
          • +2 more
          • Seongnam, Gyeonggi, Korea, Republic of
            SNUBH
          Oct 1, 2022